Possible role of caffeine in autism spectrum disorders, a new testable hypothesis

Journal of Food Science

Volumn 75, Issue 6, 2010, Pages

  Ghanizadeh, Ahmad ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE;

ANIMAL; AUTISM; CHILD; HUMAN; LETTER; MOTOR DYSFUNCTION;

ADENOSINE A1 RECEPTOR AGONISTS; ADENOSINE A2 RECEPTOR AGONISTS; ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; CAFFEINE; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; PURINERGIC P1 RECEPTOR ANTAGONISTS; STEREOTYPIC MOVEMENT DISORDER;

EID: 77955826461     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/j.1750-3841.2010.01760.x     Document Type: Letter

References (11)

1. Blaylock RL, Strunecka A. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Curr Med Chem 2009, 16(2):157-70.
2. Fisone G, Borgkvist A, Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci 2004, 61(7-8):857-72.
3. Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 2010, 75(3):R77-87.
4. Jones PA, Smith RA, Stone TW. Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res 1998, 800(2):328-35.
5. Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabi 2006, 27(3):254-89.
6. Li XX, Nomura T, Aihara H, Nishizaki T. Adenosine enhances glial glutamate efflux via A2a adenosine receptors. Life Sci 2001, 68(12):1343-50.
7. Pintor A, Quarta D, Pezzola A, Reggio R, Popoli P. SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum. Eur J Pharmacol 2001, 421(3):177-80.
8. Ribeiro JA, Sebastiao AM. Caffeine and Adenosine. J Alzheimers Dis 2010, 20(S1):3-15.
9. Solinas M, Ferre S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 2002, 22(15):6321-4.
10. Tanimura Y, Vaziri S, Lewis MH. Indirect basal ganglia pathway mediation of repetitive behavior: Attenuation by adenosine receptor agonists. Behav Brain Res 2010, 210(1):116-22.
11. Temple JL. Caffeine use in children: what we know, what we have left to learn, and why we should worry. Neurosci Biobehav Rev 2009, 33(6):793-806.